SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Venture Global, Inc. engages in the development and construction of liquefied natural gas production, establishing us as a rapidly growing company delivering critical LNG to the world. It projects include Calcasieu, Plaquemines, CP2, CP3 and Delta projects. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending sharply higher as escalating Middle East tensions disrupt global LNG supplies, particularly after Qatar's production halt and impacts on the Strait of Hormuz drove European gas prices higher. The community is actively discussing the company's strong spot market exposure and undervaluation, further buoyed by a significant legal victory against Shell and a solid Q4 earnings report, despite a recent analyst downgrade.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is experiencing a notable V-shaped rebound, with community discussion highlighting perceived market manipulation and the consistent rewarding of dip buyers, fueled by news of US efforts to secure oil flows through the Strait of Hormuz amidst escalating geopolitical tensions.

United States Commodity Funds LLC - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trending as US-Israeli strikes on Iran lead to significant disruption and reported closure of the Strait of Hormuz, a critical oil chokepoint, with community sentiment sharply divided between those anticipating a sustained rally towards elevated price levels and others expecting a rapid "sell the news" fade amid potential de-escalation talks.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending with strong community conviction fueled by the anticipated imminent, positive Phase 3 trial results for its AML cancer treatment, GPS, which many believe will lead to a significant buyout. This optimistic outlook, coupled with considerable short interest, is driving aggressive buying and short squeeze speculation, with the stock showing notable strength despite broader market weakness.

MongoDB, Inc. engages in the development and provision of a general-purpose database platform. The firm's products include MongoDB Enterprise Advanced, MongoDB Atlas, and Community Server. It also offers professional services including consulting and training. The company was founded by Eliot Horowitz, Dwight A. Merriman, Kevin P. Ryan, and Geir Magnusson Jr. in November 2007 and is headquartered in New York, NY.

MongoDB Inc - Ordinary Shares - Class A

MongoDB Inc

MongoDB is driving significant community discussion and volatility after a post-earnings sell-off, despite beating Q4 expectations, due to softer forward guidance and recent leadership changes. Investors are sharply divided between those buying the dip on strong fundamentals and AI relevance, and others anticipating further declines amid broader software sector concerns.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil is a hot topic as escalating Middle East tensions and threats to oil supply routes in the Strait of Hormuz drive energy sector volatility, with the community actively discussing its remarkable resilience against a recent $5.50 offering and speculating on a potential short squeeze to higher price levels.

SSgA Active Trust - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

XLE is trending as escalating Middle East conflicts, particularly around the Strait of Hormuz and reports of tanker attacks, drive an oil panic premium and raise concerns about global supply disruptions. The community is debating whether this surge in energy equities will be sustained or if the "war premium" is a shorting opportunity.

Target Corp. engages in the operation and ownership of general merchandise stores. It offers food and general merchandise, clothing and household goods, electronics, and toys. Its brands include A New Day, All in Motion, Art Class, Auden, AVA & VIV, Boots and Barkley, Brightroom, Bullseye's Playground, Casaluna, Cat & Jack, Cloud Island, Colsie, dealworthy, Embark, Everspring, Favorite Day, Figmint, Future Collective, Gigglescape, Good & Gather, Goodfellow & Co, Hearth & Hand with Magnolia, Heyday, Hyde & EEK! Boutique, JoyLab, Kindfull, Kona Sol, Made By Design, Market Pantry, Mondo Llama, More Than Magic, Opalhouse, Open Story, Original Use, Pillowfort, Project 62, Room Essentials, Shade & Shore, Smartly, Smith & Hawken, Sonia Kashuk, Spritz, Sun Squad, Threshold, Universal Thread, up&up, Wild Fable, Wondershop, Xhilaration, California Roots, Casa Cantina, The Collection, Headliner, Jingle & Mingle, Rosé Bae, Photograph, SunPop, and Wine Cube. The company was founded by George Draper Dayton in 1902 and is headquartered in Minneapolis, MN.

Target Corp

Target is trending as investors rally around its stronger-than-anticipated earnings and an upbeat forecast for returning to sales growth, with widespread discussion focusing on the new CEO's strategic investments in stores and digital initiatives to fuel this turnaround.

Kraken Robotics, Inc. engages in the design, manufacture, and sale of software-centric sensors, subsea batteries, thrusters and underwater robotic systems. It operates through the following geographical segments: Asia Pacific, Europe, Middle East and Africa, North America, and Other. The company was founded on May 14, 2008, and is headquartered in Mt. Pearl, Canada.

Kraken Robotics Inc

Kraken Robotics is trending intensely following a trading halt for pending news, sparking widespread community speculation around a potential acquisition or major contract. Investors are highly bullish on its advanced underwater drone and battery technology, bolstered by significant partnerships in the rapidly expanding global defense sector.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrow Health is trending after its mixed Q4 earnings and conservative 2026 guidance led to a price dip, with many in the community viewing it as a significant buying opportunity. While VEVYE sales missed near-term expectations, investors are keenly discussing the drug's recent Tier 1 formulary win with CVS and the earlier-than-expected OPUVIZ launch as potent catalysts for substantial future revenue growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MongoDB Slips Into a Super-Mongo Buying Opportunity

MongoDB's Q4 beat consensus on revenue and earnings, yet shares plunged 25% on a management shakeup. At long-term lows, the risk-reward setup is compelling...

UBS Group Has Lowered Expectations for MongoDB (NASDAQ:MDB) Stock Price

UBS Group dropped their price target on shares of MongoDB from $440.00 to $275.00 and set a "neutral" rating for the company in a research report on Tuesday...

MongoDB (NASDAQ:MDB) Price Target Cut to $400.00 by Analysts at Citigroup

Citigroup lowered their target price on shares of MongoDB from $435.00 to $400.00 and set a "buy" rating on the stock in a research note on Tuesday...

Stifel Nicolaus Issues Pessimistic Forecast for MongoDB (NASDAQ:MDB) Stock Price

Stifel Nicolaus decreased their price target on MongoDB from $450.00 to $330.00 and set a "buy" rating for the company in a research note on Tuesday...

MongoDB (NASDAQ:MDB) Given New $330.00 Price Target at Piper Sandler

Piper Sandler decreased their price objective on MongoDB from $490.00 to $330.00 and set an "overweight" rating on the stock in a research report on Tuesday...

Stocks making the biggest moves midday: MongoDB, Pinterest, NRG Energy, Kontoor Brands & more

These are the stocks posting the largest moves in midday trading...

Why MongoDB Stock Is Plummeting Today

Key PointsMongoDB's valuation is falling fast after the company's latest quarterly report...

<ul class="summary-bullets"><li>Baird cited slower-than-expected growth in Atlas revenue, raising potential questions about the company’s momentum.</li><li>Barclays analyst Raimo Lenschow trimmed the price target to $370 from $440 while maintaining an ‘Overweight’ rating.</li><li>Wedbush noted that strong quarterly results were overshadowed by a cautious outlook.</li></ul>MongoDB Inc. (MDB) is facing scrutiny on Wall Street as multiple analysts adjusted their outlooks following the company's fourth-quarter earnings report.&nbsp;While the database software provider posted solid fourth-quarter (Q4) results, concerns over revenue growth and management shifts are weighing on investor sentiment.Baird downgraded MongoDB to ‘Neutral’ from ‘Outperform’, lowering its price target to $260 from $500, according to TheFly. MongoDB forecasts first-quarter (Q1) adjusted earnings per share (EPS) between $1.15 and $1.19 per share, which is lower than the analysts’ consensus estimate of $1.21 per share.&nbsp;&nbsp;<h2 class="st-heading-2">Baird And Barclays’ Analysis&nbsp;</h2>Baird cited slower-than-expected growth in Atlas revenue, raising potential questions about the company’s momentum, despite generally strong quarterly results. The firm highlighted limited AI-related revenue and recent leadership changes as additional factors that could create pressure on the stock.Barclays analyst Raimo Lenschow trimmed the price target to $370 from $440 while maintaining an ‘Overweight’ rating. The firm noted that while MongoDB had a string of strong quarters before, the Q4 results showed a slightly smaller Atlas revenue beat and guidance for fiscal 2027.&nbsp;<a href="https://stocktwits.com/symbol/MDB/news">MongoDB stock</a> tumbled nearly 28% on Tuesday, marking its biggest single-day decline on record. On Stocktwits, retail sentiment around the stock changed to ‘extremely bullish’ from ‘bullish’ territory the previous day. Message volume shifted to ‘extremely high’ from ‘normal’ levels in 24 hours.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_03_03_105747_png_61ed9d60e0.webp" alt="MDB’s Sentiment Meter and Message Volume as of 10:30 a.m. ET on Mar. 3, 2026 | Source: Stocktwits" width="931" height="107"><figcaption>MDB’s Sentiment Meter and Message Volume as of 10:30 a.m. ET on Mar. 3, 2026 | Source: Stocktwits</figcaption></figure><h2 class="st-heading-2">Bernstein Calls Selloff An Overreaction</h2>Bernstein adjusted its price target down to $428 from $452 but kept an ‘Outperform’ rating. The firm emphasized that Q4 results were solid and the conservative FY27 guidance does not undermine its positive view on consumption growth.&nbsp;Bernstein sees the stock’s 25% drop as an overreaction, suggesting that investors may find a buying opportunity in the current selloff.Wedbush analyst Daniel Ives also cut the price target to $380 from $440 while maintaining an ‘Outperform’ stance. The firm noted that strong quarterly results were overshadowed by a cautious outlook. However, Wedbush remains optimistic about MongoDB’s ability to cash in Atlas to drive future growth.MDB stock traded over 1% lower over the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/apple-increases-prices-of-its-new-mac-book-air-and-pro-models-everything-to-know-about-its-latest-lineup/cZdeK53RIPf">Apple Increases Prices Of Its New MacBook Air And Pro Models – Everything To Know About Its Latest Lineup</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a hand holds a smartphone displaying the logo of MongoDB Inc.

MDB Stock Sees Biggest Single-Day Decline On Record: Wall Street Cuts Price Targets On Slower Atlas Growth And Cautious Outlook 

Baird downgraded MongoDB to ‘Neutral’ from ‘Outperform’, lowering its price target to $260 from $500.

Equity

Baird downgraded MongoDB to ‘Neutral’ from ‘Outperform’, lowering its price target to $260 from $500.


Barclays Lowers MongoDB (NASDAQ:MDB) Price Target to $370.00

Barclays lowered their target price on MongoDB from $440.00 to $370.00 and set an "overweight" rating for the company in a report on Tuesday...

MongoDB (NASDAQ:MDB) Shares Gap Down on Analyst Downgrade

MongoDB (NASDAQ:MDB) Shares Gap Down Following Analyst Downgrade...

$MDB Q4 &#39;26 Earnings Results &amp; Recap

MongoDB expects Q1 FY27 revenues between $659M and $664M, and full year FY27 revenues of $2.86B to $2.9B. Non-GAAP net income per share is guided to $1.15 to $1.19 for Q1.

Stocktwits

 Q4 '26 Earnings Results & Recap

MongoDB expects Q1 FY27 revenues between $659M and $664M, and full year FY27 revenues of $2.86B to $2.9B. Non-GAAP net income per share is guided to $1.15 to $1.19 for Q1.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $CRWD earnings on Tuesday?

Crowdstrike Holdings Inc

Stocktwits Polls

The stock experienced its largest single-day decline following a Q4 beat, primarily due to weaker-than-expected Q1 revenue guidance and a cautious outlook.

Traders are divided on whether the significant intraday rebound signals a true recovery or merely a "dead cat bounce" before a further drop to lower support levels.

Despite the company's crucial role in AI infrastructure, concerns arise as management stated AI is not a material driver of results yet, casting doubt on immediate monetization.

Wall Street analysts have drastically lowered price targets from highs of $500 to as low as $260, prompting discussions on their reliability and the stock's underlying value.

Current Price	$253.81
Prev Close	$325.01
Open	$235.40
Dividend Yield	0.00%
50-Day Moving Average	$384.92
Beta	1.84
Avg. Volume	1.79M
PE Ratio	-368.49

52-Week High	$444.72
52-Week Low	$140.78
Market Capitalization	$26.49B
EPS (Annual)	-$1.73
Price to Book	9.15
Revenue Per Employee	$361,000.90

MDB
MongoDB Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MDB News

MDBMongoDB Inc